Cabometyx (cabozantinib) — Medica

Initial criteria

• age ≥ 18 years
• patient has tried one systemic regimen (e.g., carboplatin, paclitaxel, trastuzumab, docetaxel, doxorubicin, cisplatin, or topotecan)

Approval duration

1 year